ARCH Venture Partners
ARCH Venture Partners is a venture capital firm that has been backing disruptive science companies for over 30 years. They are known for their contrarian, bold, and imaginative approach to investing, focusing on revolutionary technologies that can significantly impact people's lives. ARCH takes a long-term view in building companies, offering flexible investment sizes and leveraging an extensive network of partners to help companies grow from formation to full potential. Their mission is to catalyze discoveries that prevent, detect, and cure diseases, partnering with great science and amazing people to build disruptive companies globally.
Portfolio
Illumina is a leading company in the field of genomics, providing sequencing and array-based solutions for genetic analysis.
#Biotechnology
Alnylam Pharmaceuticals is known for its work in RNA interference therapeutics.
#Biotechnology
Juno Therapeutics focuses on developing innovative cellular immunotherapies for the treatment of cancer.
#Biotechnology
Receptos is involved in the development of therapeutic candidates for immune disorders.
#Biotechnology
Agios Pharmaceuticals is focused on developing treatments for cancer and rare genetic diseases.
#Biotechnology
Sage Therapeutics is dedicated to developing novel therapies for central nervous system disorders.
#Biotechnology
Bluebird Bio is a leader in gene therapy, focusing on severe genetic diseases and cancer.
#Biotechnology
Resilience is a biomanufacturing company that aims to transform the way complex medicines are made.
#Biotechnology
Codiak BioSciences is pioneering the development of exosome-based therapeutics.
#Biotechnology
Denali Therapeutics is focused on developing therapies for neurodegenerative diseases.
#Biotechnology
Karuna Therapeutics is developing novel therapies for neuropsychiatric diseases.
#Biotechnology
Beam Therapeutics is focused on precision genetic medicines using base editing technology.
#Biotechnology
Lyell Immunopharma is developing cell-based immunotherapies for cancer.
#Biotechnology
Vir Biotechnology is focused on treating and preventing serious infectious diseases.
#Biotechnology
Sana Biotechnology is working on engineered cells as medicines for a range of diseases.
#Biotechnology
Homology Medicines is focused on gene editing and gene therapy for rare genetic diseases.
#Biotechnology
Gossamer Bio is developing therapies for immunology, inflammation, and oncology.
#Biotechnology
Decode Genetics is a leader in analyzing and understanding the human genome.
#Biotechnology
Scholar Rock is developing therapies that selectively modulate growth factors for the treatment of serious diseases.
#Biotechnology
Unity Biotechnology is focused on developing therapeutics to slow, halt, or reverse diseases of aging.
#Biotechnology
Vividion Therapeutics is developing small molecule therapies for cancer and immune disorders.
#Biotechnology
Boundless Bio is developing therapies targeting extrachromosomal DNA in cancer.
#Biotechnology
Ahura Scientific, now part of Thermo Fisher Scientific, provides handheld instruments for chemical identification.
#Biotechnology
Caliper Life Sciences, now part of PerkinElmer, provides tools for drug discovery and life sciences research.
#Biotechnology
Hua Medicine is developing therapies for diabetes and other metabolic diseases.
#Biotechnology
Quanterix is a leader in digital health, providing ultra-sensitive biomarker detection technology.
#Biotechnology
Syros Pharmaceuticals is focused on gene control therapies for cancer and other diseases.
#Biotechnology
Twist Bioscience is a leader in synthetic DNA manufacturing for various applications.
#Biotechnology
Array BioPharma, now part of Pfizer, develops targeted small molecule drugs to treat cancer.
#Biotechnology